Endometriosis is a chronic disease impacting on many aspects of a woman’s life. Because of the chronic and recurring nature, many of the impacts of endometriosis could be missed using existing questionnaires which focus on recent events. Therefore, a questionnaire with a long-term perspective is necessary. This study aimed to develop and evaluate a questionnaire to measure the long-term impact of endometriosis on different aspects of women’s lives.
Methods
Through a methodological design, phase 1 was qualitative and phase 2 was a cross-sectional study. The original 100 EIQ items were developed based on results from an earlier qualitative study and literature review. Through a process of assessing face and content validity this was reduced to 66 items. The psychometric properties of the final 63 item EIQ were evaluated through a web-based survey with data from 423 responders with a self-reported surgically-diagnosed endometriosis.
Results
Participants were aged 16-58 years. Exploratory factor analysis of a 66-item EIQ was established with 423 responders. The final 63-item EIQ contained six dimensions including: 33-item physical-psychosocial; 3-item fertility; 7-item sexual; 11-item employment; 6-item educational; and 3-item lifestyle. Cronbach’s alpha of 0.99 for the whole 63-item EIQ, and 0.84 to 0.98 for the dimensions suggests a very good reliability. High positive correlations between the EIQ and the EHP-5 (altered recall period) indicated good evidence of concurrent validity. High intra-class correlations indicated very good test-retest reliability.
Conclusions
The EIQ, as a disease-specific questionnaire, could be used to provide a better understanding of the impact of endometriosis on different aspects of life, to better meet the needs of women. We recommend additional studies to establish validity evidence for the EIQ, including studies in other countries and languages.
Endometriosis is a high prevalence condition causing chronic pelvic pain, and the third leading cause of gynaecological hospitalization in the United States with high rates of hysterectomy [1]. Endometriosis requires lifelong management [2] and treatment must be individualized, taking into account the entire clinical problem, including disease impact and effects of treatment on quality of life (QoL) [3]. The most widely used instruments are the generic Health-Related Quality of Life (HRQoL) questionnaire including the Short Form–36 version (SF-36) [4, 5], the short version of the World Health Organization QoL (WHOQOL-BREF) [6, 7], and the EuroQol-5D [8]. However, the general HRQoL questionnaires do not consider unique variables related to endometriosis such as infertility [9] and the impact of symptoms other than pain. There are some specific questionnaires including Endometriosis Health Profile-30 (EHP-30) [10] and its subset, the EHP-5 [11], Endometriosis Treatment Satisfaction Questionnaire (ETSQ) [12], daily electronic Endometriosis Pain and Bleeding Diary (EPBD) [13], and ‘Patient-Centred Endometriosis’ questionnaire of Endo Care Questionnaire (ECQ) [14] but the EHP-30 is currently the disease-specific questionnaire to measure the HRQoL with the strongest validity evidence [9].
Published studies assessed the impact of endometriosis on pain using the VAS, depression using the BDI or HAM-D, anxiety using STAI or HAM-A [7], work impairment using WPAI [5, 8], sexual satisfaction using GRISS [6] and the GSSI [15], and sexual function using the FSDS or FSFI [16], and DSFI [15]. There is limited research on the psychological impacts of endometriosis except for depression/anxiety, work, education, social life, and lifestyle.
Anzeige
Existing tools only asses a subset of QOL indicators, and measure disease impact with a perspective of four weeks or less. Due to the chronic, recurring nature of endometriosis, many disease impacts could be missed, so a multi-dimensional questionnaire with a longer-term perspective is necessary to provide a better understanding. Women’s perceptions of the impact of endometriosis have been explored through our earlier qualitative study [17]. We have now developed and evaluated the psychometric properties of a questionnaire to measure the longer-term impact of endometriosis on different aspects of women’s lives.
Methods
The Endometriosis Impact Questionnaire (EIQ) is a self-report questionnaire which asks women how endometriosis has affected their lives over the three recall periods including ‘last 12 months’, ‘1 to 5 years ago’ and ‘more than 5 years ago’. Categorical responses for all EIQ items are ranked using a 5 point Likert scale including: 0 = Not at all, 1 = A little, 2 = Somewhat, 3 = Quite a lot, 4 = Very much and 9 = Not applicable. Each item contributes equally and higher scores indicate a greater impact. The EIQ was developed and a psychometric evaluation conducted, using face, content, construct (factor analysis), concurrent validity, and reliability (internal consistency and test-retest reliability). The study used a methodological design which involved the development and evaluation of data collection instruments, scales or techniques [18]. To evaluate construct and concurrent validity and reliability, a cross-sectional study was conducted via a web-based survey. The development process is illustrated in Figure 1. All data were analyzed using SPSS version 20, and a probability values of p< 0.05 were considered to be statistically significant.
Fig. 1
Development process of the EIQ
×
Developing the items of the EIQ
The original 100 EIQ items were developed from a qualitative study [17] and from a systematic literature review. Eight steps on scale development [19], and the criteria for selecting items [20], were followed. The readability of the EIQ based on the Fog index [21] and ‘Readability Formulas’ [22] were used. In addition, endometriosis patients and experts were asked to evaluate readability of items [21].
Evaluating the psychometric properties
Validity
The adequacy of a scale as a measure of a specific variable is an issue of validity [19]. The initial 100-item EIQ was evaluated to delete repeated items or those which related to only a few women from the focus groups discussions [17], so it was reduced to 89 items.
Face validity
Feedback was sought from 12 patients and 14 health professionals with expertise in endometriosis, questionnaires development, chronic disease, and psychology. They reviewed the 89-item EIQ and answered three open questions; 1. Does this appear to be a good measure of the impact of endometriosis? 2. List any areas pertinent to the impact of that are not covered 3. Share with us your feedback or any other comments to improve the EIQ.
Content validity
For the content validity index (CVI) [21], we asked the same 12 patients and 14 health professionals to review the 89-item EIQ and rate the items based on ‘Relevance’, ‘Clarity’ and ‘Simplicity’ on a four-point scale. The CVI was measured as a percentage of the items rated as 3 or 4 [23, 24]. Item-level content validity index (I-CVI) was computed as the number of experts giving a rating of either 3 or 4, divided by the total number of experts [25]. A CVI or S-CVI of 0.80 was considered as indicating acceptability [23]. Following these steps the EIQ was reduced to 66 items.
Construct validity
The initial EIQ had randomly-ordered items to avoid hypothesised factor structure. But considering the number of items and the three recall periods, random-ordering made the EIQ difficult and time consuming to complete. Some experts suggested arranging the items in logical groups rather than having the items all mixed up, to make it easier to complete by responders. Therefore, the initial EIQ with randomly-ordered items was divided into logical groups based on categories which emerged from results of an earlier qualitative study [17], but the main categorizing of the EIQ was made based on exploratory factor analysis. The 66-item EIQ was then subjected to exploratory factor analysis to assess construct validity [26]. The commonly used method of principal component analysis and varimax rotation was used [27]. For this study, the acceptable level for factor loading was equal to or greater than 0.40 [28], and eigenvalues greater than one [27] were considered. The required sample size was estimated at 350 to 400 to have subject-to-variable ratio of 5:1, which identified as adequate in most cases [26].
Concurrent validity
There is no comparable questionnaire with a long-term perspective so to assess concurrent validity the EHP-5 [11] was chosen and the recall period changed from the ‘last 4 weeks’ to ‘last 12 months’.
Reliability
Two frequently used indicators of a scale’s reliability, including internal consistency (Cronbach’s alpha) and stability (Pearson correlation coefficient (r), test-retest reliability) were evaluated [26].
Internal consisten3cy reliability
Strong item-total correlations were identified as above 0.30 and inter-item correlations as ranging 0.30-0.70 [29]. In this study, a Cronbach’s alpha ≥ 0.7 was considered satisfactory and a corrected item-to-total correlation of at least 0.3 was considered as acceptable.
Test-retest reliability
To determine test-retest reliability, two copies of the final version were posted to 70 patients, who completed a first copy on the day that they received it, and a second copy after two weeks. Statistical differences between the two scores were assessed.
Sample and setting
Convenience and snowball sampling were used to recruit a sufficiently large number of accessible participants, with an emphasis on those residing in Australia. Inclusion criteria were self-reported surgically-diagnosed endometriosis and ability to understand English. A web-based survey was conducted and recruitment was through different strategies from secondary or tertiary care levels, as well as from the general community. The EIQ-link was widely advertised via flyers disseminated or posted. Many groups and people (like endometriosis centres and endometriosis support groups) were asked to assist by forwarding an invitation email to their databases and/or by putting flyers in their centres or on their website/Facebook pages.
Anzeige
Pilot study
A pilot study was conducted for the EIQ paper version and then for the EIQ online version. The EIQ paper version was finalized and pilot tested with eight patients in July 2013 and all responders provided positive feedback, stating that “It is comprehensive” and “It is clear”. The online EIQ was developed using ANU Polling Online (APOLLO) in August 2013 (Link: https://apollo.anu.edu.au/default.asp?pid=7700) and was pilot tested with four patients in September 2013. Feedback was generally positive stating that “It worked fine” and “The instructions are very clear”.
Results
EIQ item generation
The first draft of the EIQ included 100 items which reduced to 89. Face validity, content validity and further revisions resulted in a decrease to 66 items, and this version was used to assess factor analysis, concurrent validity, and test-retest reliability. Through factor analysis, three items were deleted and 63 items formed the final EIQ (Additional file 1).
Demographic and clinical characteristics of responders
A total of 484 responders completed the final 63-item version between September 2013 and February 2014. One was excluded for providing incorrect completion; all 483 remaining questionnaires were fully completed. A further 60 responders were excluded as they did not have surgically-diagnosed endometriosis. Data from the remaining 423 responders were used to assess the psychometric properties of the EIQ. Demographic and clinical characteristics are provided in Table 1.
Table 1
Demographic and clinical characteristics of women with endometriosis (n=423)
Characteristics
n (%)
Agea (years)
32.64± 8.38, (Range: 16-58)
Age groups
Aged 16-24
75 (17.73)
Aged 25-34
186 (43.97)
Aged 35 and above
162 (38.30)
Country of birth
Australia
313 (74.00)
Other
110 (26.00)
Country at time of doing the EIQ
Australia
351 (82.98)
Other
72 (17.02)
Language is spoken at home
English
418 (98.82)
Other
5 (1.18)
Marital status
Married
187 (44.21)
In a relationship
129 (30.50)
Never married
48 (11.35)
Single
45 (10.64)
Separated/Divorced
13 (3.07)
Widowed
1 (0.24)
Educational level
Primary or high school
14 (3.31)
Lower secondary school
22 (5.20)
Upper secondary school
47 (11.11)
Vocational (e.g. TAFE)
79 (18.68)
Some college/university
42 (9.93)
Tertiary, undergraduate
131 (30.97)
Tertiary, postgraduate
76 (17.97)
Other
12 (2.84)
Employmentb
Not employed
43 (10.17)
Paid work, full time
200 (47.28)
Paid work, part time
119 (28.13)
Home duties
47 (11.11)
Student, full time
30 (7.09)
Student, part time
22 (5.20)
Retired
3 (0.71)
Other
38 (8.98)
Pregnancy historyb
Never pregnant
237 (56.03)
One or more children
126 (29.79)
Miscarriage or stillbirth
64 (15.13)
Currently pregnant
10 (2.36)
Delayed fertility
Not applicable (never tried)
194 (45.86)
No
69 (16.31)
Yes
160 (37.83)
Age at onset of symptomsa (years)
16.35± 5.21, (Range: 8-42)
Age at first visit to doctora (years)
19.70±6.49, (Range: 9-43)
Age at diagnosisa (years)
24.65± 6.58, (Range: 12-43)
Delay in diagnosisa (years)
8.31±6.58, (Range: 0-28)
Endometriosis-related symptomsb (life time).
Period pain
420 (99.29)
Fatigue
397 (93.85)
Bloating
386 (91.25)
Pelvic pain not related to periods
382 (90.31)
Ovulation/mid cycle pain
377 (89.13)
Pain during/after sex
354 (83.69)
Heavy bleeding
345 (81.56)
Irregular bleeding
271 (64.07)
Delayed fertility
158 (37.35)
Other
91 (21.51)
Endometriosis treatmentsb (life time)
Pain killers
410 (96.93)
Surgical treatments
394 (93.14)
Hormonal medications
368 (87.00)
Complementary treatments
208 (49.17)
Hormonal IUD
175 (41.37)
Psychologist
120 (28.37)
Nutritionist
95 (22.46)
Physiotherapist
72 (17.02)
Sexual therapist
15 (3.55)
Other
48 (11.35)
Times presented to emergency department due to endometriosis
Never
165 (39.01)
1-2
118 (27.90)
3-4
55 (13.00)
5-10
44 (10.40)
More than 10
41 (9.69)
Hysterectomy due to endometriosis
No
376 (88.89)
Yes
47 (11.11)
aMean±SD
bParticipants were asked to tick all that apply
Readability of the EIQ
Gunning Fog Index was 8.7 for the 66-item EIQ and 8.6 for the 63-item EIQ, both of which are considered as ‘fairly easy to read’. Based on seven readability formulae the EIQ was scored as grade level 6, which means a standard/average reading level suitable for readers aged 10-11 years (fifth and sixth graders).
Face validity
Most believed that the EIQ was ‘comprehensive’ and a ‘good’ measure of the impact of endometriosis. Only one patient and four of the experts reported that the 89-item EIQ was too long and suggested reviewing it for redundant items.
Content validity
Content validity of the 89-item EIQ was based on seven out of 14 experts and six out of 12 patient’s ratings. The inter-rater agreements were 0.84 (experts) and 0.93 (patients). S-CVI and I-CVIs indicated acceptable content validity for both the EIQ and its items. Although, based on I-CVIs only two out of 89 items required deletion or change, a further 21 items were deleted to shorten to 66 items; these were items that overlapped, or had a low score on clarity or simplicity.
Construct validity
A sample size of 423 was adequate for factor analysis based on a Kaiser-Meyer-Olkin (KMO) test result of more than 0.9 and a Bartlett’s test of sphericity that was significant (p < 0.01). An inspection of the scree plot revealed a break after six or seven factors. All items with a factor loading of 0.4 and above were retained. The results from the factor analysis of the EIQ and each of three recall periods including ‘last 12 months’, ‘1 to 5 years ago’ and ‘more than 5 years ago’ were consistent to support having six separate factors for physical-psychosocial, fertility, sexual, employment, educational and lifestyle. The exception was that in the ‘more than 5 years ago’ period some of the physical items were loaded into a separate factor. However, to have consistent factor dimensions, it was decided to include the physical items into the physical-psychosocial dimension. Factor analysis with six factors explained 58.14, 53.84, 52.86, and 46.09 of the total variance in recall period of ‘last 12 months’, ‘1 to 5 years ago’, ‘more than 5 years ago’, and the total EIQ respectively. Three items were removed from the 66-item EIQ because they did not reach a 0.4 factor loading. In comparison with the primary EIQ categorizing, factor analysis identified a new dimension which was called fertility, combined the physical, psychological and social items into one factor called physical-psychosocial, and transferred some items between dimensions.
Final EIQ
The final EIQ with 63 items had six dimensions: (1) physical-psychosocial - 33 items (consisting of physical – 13 items, psychological- 16 items and social impact – 4 items); (2) fertility - 3 items; (3) sexual - 7 items; (4) employment - 11 items; (5) educational - 6 items; and (6) lifestyle - 3 items (Additional file 1).
Concurrent validity
There were statistically significant high positive correlations (r=0.66-0.80, (n=423), p < 0.01) between the ‘last 12 months’ of the EIQ and the EHP-5 (Table 2), indicating that patients who experienced a greater impact (higher EIQ score) had worse health-related quality of life (higher score from the EHP-5). Therefore, the recall period of ‘last 12 months’ for the EIQ, had high concurrent validity or very good correlation with the EHP-5. Correlations were good (r = 0.40-0.58) when the EHP-5 was compared with the ‘1 to 5 years ago’ period of the EIQ, and medium or low (r = 0.17-0.45) when compared with the ‘more than 5 years ago’ period of the EIQ, except for sexual dimension and intercourse module, which was good at a level of p= 0.45.
Table 2
Concurrent validity correlations of the ‘last 12 months’ EIQ dimensions with the EHP-5 scales (n = 423)
EIQ (last 12 months)
EHP-5
Number
Pearson Correlationa
Physical-psychosocial
EHP-5 (score from 5 core items)
412
.80
Physical
Pain
407
.66
Psychological
Q2,3, & 5 of the core questionnaireb
409
.75
Social
Social support
402
.64
Sexual
Intercourse
363
.71
Fertility
Infertility
348
.66
Employment
Work
360
.66
aAll Correlations were significant at the 0.01level (2-tailed) using Pearson Correlation
bControl & powerlessness, emotional wellbeing and self-image
EIQ Scoring
The score for each dimension at each recall period was the sum of all applicable items divided by the maximum score, rescaled to 0-100. The total score for each dimension was calculated as a mean of the three recall periods. If responders skipped a dimension or recall period, because they were not applicable to them, a score for that dimension or recall period could not be calculated.
An SPSS code was provided to score the EIQ. The formula for scoring the EIQ and its dimensions on a scale from 0-100 was the sum of the scores of the applicable items multiplied 100/the maximum score of the applicable items, which was the number of applicable items x 4. The dimensions were scored on a scale from 0 (minimum possible impact), to 100 (maximum possible impact) as measured by the EIQ.
The EIQ scores for the sample as a whole, and the distribution of the scores are reported in Table 3. At each recall period, and also over a total of three recall periods, the highest impact of endometriosis was on fertility followed by the physical-psychosocial dimension, and the lowest impact was on the lifestyle dimension.
Table 3
Descriptive statistics of the EIQ dimension scoring
EIQ dimensions
Last 12 months
1 to 5 years ago
More than 5 years ago
Total three recall periods
Physical-Psychosocial
Mean ± SD
62.69 ± 27.25
64.27 ± 23.90
56.12 ± 24.90
61.10 ± 21.28
Number a
412
418
401
390
Minimum (%)
.00 (1.9)
.00 (1.4)
.00 (.9)
6.31 (.9)
Maximum (%)
100.00 (1.9)
100.00 (1.9)
100.00 (1.4)
100.00 (1.4)
25
44.70
50.00
38.11
46.81
Percentile 50
68.56
68.94
58.00
63.52
75
85.61
82.58
75.38
77.28
Physical
Mean ± SD
62.46 ± 27.38
64.46 ± 23.61
58.93 ± 24.50
61.88±20.51
Number
407
416
400
384
Minimum (%)
.00 (2.6)
.00 (2.1)
.00 (.9)
8.97 (.2)
Maximum (%)
100.00 (4.3)
100.00 (4.0)
100.00 (3.5)
100.00 (1.4)
25
46.15
51.92
40.91
47.09
Percentile 50
68.75
67.31
61.54
63.46
75
84.62
81.25
76.92
76.28
Psychological
Mean ± SD
65.00 ± 27.89
66.21 ± 25.07
57.26 ± 27.31
62.76 ± 22.89
Number
409
416
389
375
Minimum (%)
.00 (1.9)
.00 (2.4)
.00 (3.5)
1.56 (.2)
Maximum (%)
100.00 (4.0)
100.00 (3.8)
100.00 (3.3)
100.00 (1.7)
25
48.44
50.00
39.06
46.15
Percentile 50
71.88
72.60
59.38
67.19
75
87.50
84.38
78.59
79.69
Social
Mean ± SD
54.81 ± 34.89
56.01 ± 32.20
47.23 ± 32.67
52.44 ± 29.09
Number
402
407
373
352
Minimum (%)
.00 (11.3)
.00 (8.5)
.00 (11.6)
.00 (4.3)
Maximum (%)
100.00 (16.8)
100.00 (13.9)
100.00 (10.6)
100.00 (5.9)
25
25.00
31.25
18.75
29.17
Percentile 50
62.50
56.25
43.75
54.17
75
87.50
81.25
75.00
76.56
Sexual
Mean ± SD
47.24 ± 28.65
47.87 ± 27.93
40.88 ± 29.89
45.53 ± 26.77
Number
375
381
343
320
Minimum (%)
.00 (3.5)
.00 (3.8)
.00 (1.9)
.00 (.2)
Maximum (%)
100.00 (5.4)
100.00 (3.8)
100.00 (1.9)
100.00 (2.4)
25
25.00
25.00
44.70
22.92
Percentile 50
50.00
46.43
68.56
44.05
75
67.86
71.43
85.61
67.86
Fertility
Mean ± SD
70.23 ± 37.59
67.78 ± 36.86
58.24 ± 38.90
65.28 ± 32.70
Number
391
390
347
323
Minimum (%)
.00 (13.2)
.00 (11.3)
.00 (14.7)
.00 (4.0)
Maximum (%)
100.00 (46.1)
100.00 (41.1)
100.00 (27.0)
100.00 (18.9)
25
37.50
37.50
25.00
33.33
Percentile 50
91.67
83.33
66.67
75.00
75
100.00
100.00
100.00
97.22
Employment
Mean ± SD
43.89 ± 34.77
43.66 ± 32.78
35.24 ± 32.40
41.04 ± 30.42
Number
385
392
357
334
Minimum (%)
.00 (10.2)
.00 (6.4)
.00 (11.3)
.00 (2.4)
Maximum (%)
100.00 (9.0)
100.00 (6.9)
100.00 (5.2)
100.00 (3.5)
25
11.36
15.91
8.71
14.20
Percentile 50
36.36
34.69
25.00
32.95
75
75.00
72.67
60.56
64.58
Educational
Mean ± SD
46.61 ± 39.32
45.48 ± 35.76
43.99 ± 33.71
43.78 ± 31.28
Number
173
206
241
149
Minimum (%)
.00 (10.2)
.00 (8.5)
.00 (6.6)
.00 (2.4)
Maximum (%)
100.00 (7.1)
100.00 (7.1)
100.00 (6.1)
100.00 (2.4)
25
2.08
8.33
12.50
16.67
Percentile 50
45.83
43.75
37.50
38.89
75
83.33
79.17
75.00
70.83
Lifestyle
Mean ± SD
16.54 ± 23.88
20.48 ± 26.78
20.75 ± 28.76
19.43 ± 24.44
Number
391
397
367
342
Minimum (%)
.00 (46.6)
.00 (43.0)
.00 (42.6)
.00 (29.8)
Maximum (%)
100.00 (2.4)
100.00 (2.8)
100.00 (3.5)
100.00 (1.7)
25
.00
.00
.00
.00
Percentile 50
.00
8.33
8.33
8.33
75
25.00
33.33
33.33
33.33
aNumber of responders for whom that dimension at that recall period was applicable. Regarding the total scores, if responders skipped one of the recall periods, the total score for that dimension was not calculated
The scores were calculated on a scale from 0-100; a higher score means a greater impact of endometriosis on that dimension of life. 0=Minimum impact of endometriosis as measured by the EIQ; 100= maximum possible impact of endometriosis as measured by the EIQ
Out of 423 responders, 26 (6.1%) participants skipped items from the sexual dimension, 26 (6.1%) participants skipped items from the employment dimension, 152 (35.9%) participants skipped items from the education dimension, and 8 (1.9%) participants skipped items from the fertility and lifestyle dimensions
Completion time of the EIQ
The estimated completion time for the 66 item EIQ was 4.8-31.5 minutes with a mean ± SD of 15.2 ± 6.2 minutes.
Reliability
The internal consistency reliability of the 63-item EIQ and the six dimensions was Cronbach’s alpha 0.98 (Table 4). Results showed good reliability in all dimensions but the physical-psychosocial dimension had the highest and the lifestyle dimension had the lowest Cronbach’s alpha for all three recall periods.
Table 4
Internal consistency of the 63-item EIQ and its dimensions
Numbera
last 12 months
1 to 5 years ago
more than 5 years ago"
Total three recall periods
EIQ total
423
.97 (63 items)
.97
.97
.98(189 items)
Physical-psychosocial
423
.97 (33 items)
.96
.95
.98 (99 items)
Physical
423
.92 (13 items)
.90
.90
.94 (39 items)
psychological
423
.95 (16 items)
.93
.92
.96 (48 items)
Social
423
.91 (4 items)
.90
.88
.93 (12 items)
Sexual
397
.84 (7 items)
.85
.86
.93 (21 items)
Fertility
415
.73 (3 items)
.73
.66
.85 (9 items)
Employment
397
.94 (11 items)
.94
.94
.97 (33 items)
Educational
271
.93 (6 items)
.92
.91
.93 (18 items)
Lifestyle
415
.53 (3 items)
.57
.62
.84 (9items)
Cronbach’s alpha was evaluated
aOnly responders who skipped all items of the dimension (all three recall periods) were omitted
In the 63-item EIQ, all items correlated to total items at a level above 0.3 except for item numbered Q41, which correlated to total items at a level of 0.2. Cronbach's alpha for each recall period of the EIQ was 0.97 across the 63 items, indicating very good reliability. In each recall period, all items correlated to total items at a level above 0.3 except for two items, which correlated to total items at a level of 0.2. Within each dimension in each recall period, all items correlated to total items at a level above 0.3.
Results of the inter-scale correlation matrix is shown in Table 5. Only responders who answered for both dimensions were included. All correlations were positive and statistically significant and there were high correlations between most dimensions at all recall periods.
Table 5
Inter-scale correlation matrix for the last 12 months, 1 to 5 years ago, More than 5 years ago
Physical-psychosocial
Sexual
Fertility
Employment
Educational
Lifestyle
Physical-Psychosocial
1.00
Sexual
.63a
1.00
.64b
.63c
Fertility
.41a
.29a
1.00
.37b
.24b
.47c
.33c
Employment
.74a
.53a
.31a
1.00
.72b
.54b
.24b
.70c
.55c
.35c
Educational
.59a
.43a
.16a
.72a
1.00
.60b
.47b
.20b
.69b
.62c
.45c
.27c
.70c
Lifestyle
.37a
.32a
.13a
.31a
.30a
1.00
.38b
.28b
.13b
.31b
.33b
.48c
.44c
.17c
.43c
.32c
Pearson correlation coefficient (r) was evaluated
aLast 12 months: All Correlations were significant at the 0.01level (2-tailed) except for fertility-education and fertility-lifestyle, which were significant at the 0.05 level (2-tailed)
b1 to 5 years ago: All correlations were significant at the 0.01level (2-tailed) except for fertility-lifestyle, which was significant at the 0.05 level (2-tailed)
cMore than 5 years ago: All correlations were significant at the 0.01level (2-tailed)
Test-retest reliability (stability)
Test retest reliability using intra-class correlation (ICC) was conducted in 40 out of 70 (60%) respondents who completed the second test after a two-week interval using the EIQ paper version. The results showed a statistically significant ICC between all dimensions at times one and 2, ranging from 0.88-0.99. The results indicate that the EIQ has very good test-retest reliability.
Discussion
This study shows that the EIQ is a valid, reliable tool to measure the impact of endometriosis on women’s lives with a long-term view. Endometriosis is a chronic disease as symptoms may continue despite seemingly adequate treatment [30]. Considering its recurring nature, there are some impacts that could be missed by only looking at the last four weeks. For example, current questionnaires are not able to measure the impacts on a woman who lost her sexual-intimate relationship or who was not able to complete studies and/or work goals, loss of job or promotion opportunities, or addressed her regrets from living with endometriosis. These impacts were revealed during our earlier qualitative study [17] and are supported by others [31, 32]. The EIQ is the first questionnaire to measure multi-dimensional impacts with a long-term view.
Validation of a scale involves the collection of empirical evidence concerning its use26. Similar to the EIQ, the ETSQ [12] and the EPBD [13] were developed from focus group discussions and interviews with patients. Items of the EHP-30 were generated based on open-ended exploratory interviews with 25 women with endometriosis [10]. The process used to validate the EIQ was to some extent similar to the one employed for the ECQ [14], however the development processes were different.
Compared with the EHP-30 [10], the EIQ has two new subscales of education and lifestyle, whilst the EHP-30 has subscales of relationship with children, medical professionals, and treatment. Little is known about the impacts of endometriosis on lifestyle but negative impacts were reported during our earlier study [17]. Future studies should be conducted to measure the impact of endometriosis on lifestyle, as well as education and work which extend beyond time off and lost productivity addressed in previous studies [5, 8].
The demographic and medical characteristics of the responders in this study are consistent with endometriosis patients in previous research, increasing the generalizability of results. In a multinational study [5], 745 participants had a mean age of 32.5 years and a mean delay in diagnosis of 6.7 years, similar to the mean age (32.6) and delay (8.3) in this study. In an online survey most of 8008 patient (from China, France and Russia) were diagnosed within five years [33]. Thirty-eight percent of EIQ responders had delayed fertility, consistent with the infertility rate of 37% among 6,146 European patients [34] and 42.5% among 7,020 US patients [35]. Eleven percent had a hysterectomy because of endometriosis, which is within the range of 8-29% reported by others [36].
Anzeige
The self-reporting characteristic of the EIQ has pros and cons. Sensitive information is more frequently and accurately reported in self-administered modes than when interviewers ask the questions [37]. However, limitations related to reporting and recall errors may apply because of the self-reported and retrospective nature of the EIQ. Questionnaire developers can overestimate people’s ability to recall past events [20]. However, life time recall period has been used previously with satisfactory psychometric characteristics [14]. The decision to have three recall periods was based on focus group discussions where women reported fluctuations in the impacts, variety of symptoms at different times, and differing perceptions of impacts based on their situation, desires, responsibilities and plans [17]. It is acknowledged that using multiple time frames might complicate the questionnaire and overburden respondents but the completion time of the EIQ was reasonable.
Applications of the EIQ
Use of disease-specific instruments in endometriosis research has been highlighted and preferred in recent literature reviews [9, 38]. The EIQ, as a disease-specific questionnaire, could be used to provide detailed information on the multi-dimensional impacts of endometriosis in population health surveys, to compare different areas and stages of patients’ lives or different management options. It could be used with all three recall periods or each period independently, because each has satisfactory validity and reliability. The total score for each dimension at three recall periods, for all dimensions at each recall period and the total impact score could be calculated. Combining the scores will depend on the research objectives. Using the recall period of ‘last 12 months’, could be used in clinical trials and to investigate outcomes. It could be useful to guide development of an individualized disease management plan, and could help patients to communicate with health professionals and contribute to such a plan. It could also be used as a burden-estimation or needs assessment tool to provide information for making health policy decisions to improve services.
Strengths of this study
The EIQ was developed from focus group discussions, along with an extensive literature review, which ensured that the items are relevant to patients from either tertiary care or the community. A sample of 423, reflected 6.41 responders per item, is close to being a ‘very good’ sample size [39]. There were no missing data as most items were compulsory in the online EIQ, but even those who answered the paper version for the test-retest did not miss any questions. The online questionnaire facilitated access to women within and beyond Australia, which was time and expense-saving.
Limitations of this study
Non-probability sampling decreases the ability to generalize results. Dissemination of the study link was focused inside Australia and 74% of responders to the online EIQ were born in Australia. Therefore, the applicability to Australian women with different characteristics to the participants, and non-Australians might be limited. Limitations related to reporting and recall errors may apply. As a web-based survey was used, the generalizibility of the results is restricted to those who are keyboard and Internet literate [40]. In addition, the current study did not collect clinical information regarding the severity of endometriosis lesions and the existence of comorbidities, such as mood disorders, obesity, musculoskeletal and neuropathic sources of pain, and patients undergoing treatment with psychotropic drugs that could also contribute to symptoms, and it is acknowledged that not knowing these clinical characteristics of the sample could limit the generalizability of the findings.
Anzeige
Conclusions
The EIQ has been developed and validated to measure the impacts of endometriosis on different aspects of women’s lives with a long-term view. It can be used by researchers and clinicians to provide a better understanding of the impact of endometriosis on different aspects of life over time, and to meet the needs of women living with this condition. We recommend additional studies to establish stronger psychometric properties including known-groups validity and sensitivity to change for the ‘last 12 months’ section. Further validity evidence is also recommended in clinically relevant subgroups of endometriosis patients, such as women presenting for fertility evaluations versus women presenting with chronic pelvic pain, as well as endometriosis patients with the comorbid conditions. Studies in other countries and languages are recommended to make multinational studies possible.
Acknowledgements
This article has been derived from a thesis submitted for the degree of Doctor of Philosophy at the Australian National University Medical School. We thank the participants for completing the questionnaire (EIQ) and helping us to make this study possible. We acknowledge the experts who provided valuable comments and feedback about the EIQ and many organizations and people who helped this study by disseminating the online questionnaire link.
Ethical considerations and consent to participate
Approvals were obtained from the ACT Health Human Research Ethics Committee (ETH.6.13.155), and from the ANU Human Research Ethics Committee. The first page of the EIQ included a brief information form, and it was stated that “Completing this questionnaire is voluntary. By completing the questionnaire you are indicating your consent to participate in the study”. Online EIQ was an anonymous web-based survey, and could be completed without a log in.
Competing of interests
The authors declare that they have no competing interests.
Anzeige
Funding
This research, including design of the study; collection, analysis, and interpretation of data; and the writing of the manuscript, has been supported by the Australian National University (ANU), School of Medicine within a PhD candidature.
Availability of data and materials
The datasets generated and analysed during the current study and more information regarding using the EIQ or scoring details will be available from the corresponding author on reasonable request.
Consent for publication
Not applicable.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
